Alpha Cognition Files 8-K/A Amendment
Ticker: ACOG · Form: 8-K/A · Filed: Sep 26, 2024 · CIK: 1655923
Sentiment: neutral
Topics: amendment, financial-statements, exhibits
TL;DR
Alpha Cognition filed an amendment to its 8-K, adding/correcting financial statements and exhibits.
AI Summary
Alpha Cognition Inc. filed an amendment (8-K/A) on September 26, 2024, to its current report originally filed on September 24, 2024. This amendment pertains to financial statements and exhibits, with the earliest event reported being September 24, 2024. The company, formerly known as Neurodyn Cognition Inc., is incorporated in British Columbia and has its principal executive offices in Vancouver.
Why It Matters
This filing is an amendment to a previous report, indicating a correction or addition to previously disclosed information, which could be material for investors.
Risk Assessment
Risk Level: low — This is a procedural amendment to a previous filing, not a new event or significant financial disclosure.
Key Players & Entities
- Alpha Cognition Inc. (company) — Registrant
- September 24, 2024 (date) — Date of earliest event reported
- September 26, 2024 (date) — Filing date of amendment
- Neurodyn Cognition Inc. (company) — Former company name
- Vancouver (location) — Principal executive offices location
FAQ
What is the purpose of this 8-K/A filing?
This filing is an amendment (No. 1) to a previously filed Current Report (Form 8-K), specifically addressing financial statements and exhibits.
When was the earliest event reported in this filing?
The earliest event reported is September 24, 2024.
What was Alpha Cognition Inc. formerly known as?
Alpha Cognition Inc. was formerly known as Neurodyn Cognition Inc.
Where are Alpha Cognition Inc.'s principal executive offices located?
The principal executive offices are located at 1200 – 750 West Pender Street, Vancouver, British Columbia, V6C 2T8.
What is the SIC code for Alpha Cognition Inc.?
The Standard Industrial Classification (SIC) code is 2836, for Biological Products (No Diagnostic Substances).
Filing Stats: 460 words · 2 min read · ~2 pages · Grade level 11.8 · Accepted 2024-09-25 18:20:30
Filing Documents
- ea021571201-8ka_alpha.htm (8-K/A) — 24KB
- ea021571201ex10-1_alpha.htm (EX-10.1) — 343KB
- 0001213900-24-081881.txt ( ) — 617KB
- acogf-20240924.xsd (EX-101.SCH) — 3KB
- acogf-20240924_lab.xml (EX-101.LAB) — 33KB
- acogf-20240924_pre.xml (EX-101.PRE) — 22KB
- ea021571201-8ka_alpha_htm.xml (XML) — 4KB
01 Financial Statements, Pro Forma
Item 9.01 Financial Statements, Pro Forma Financial Information and Exhibits. (d) Exhibits: Exhibit Description 10.1* Securities Purchase Agreement dated September 24, 2024 104 Cover Page Interactive Data File (embedded within the Inline XBRL document) *- Certain schedules and exhibits have been omitted pursuant to Item 601(b)(2) of Regulation S-K. A copy of any omitted schedule and/or exhibit will be furnished to the SEC upon request 1 SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. ALPHA COGNITION INC. By: /s/ Michael McFadden Michael McFadden Chief Executive Officer Dated: September 25, 2024 2